Tag: pediatric exclusivity

Market Exclusivity Extensions: How Pharma Companies Extend Monopolies Beyond Patents

By Lindsey Smith    On 18 Jan, 2026    Comments (11)

blog-post-image

Market exclusivity extensions let drug companies block generics for years after patents expire. Learn how NCE, orphan, pediatric, and other regulatory protections create hidden monopolies in pharmaceuticals.

View More

Categories

Recent Post

recent-post-image How to Access FDA Adverse Event Data: FAERS Dashboard, Tools, and Transparency Guide
recent-post-image International Perspectives on NTI Generics: Regulatory Approaches Compared
recent-post-image Top Alternatives to Spironolactone: Exploring Viable Options
recent-post-image Asthma and COPD Inhalers: How to Use Them Correctly for Better Results
recent-post-image Digital Pill Sensors: How Adherence Insights and Side Effect Detection Are Changing Medication Management

Menu

© 2026. All rights reserved.